Feedback / Questions
camidanlumab tesirine (ADCT-301) - Genmab, ADC Therapeutics
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT03621982
Dec 15, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next